Status:
COMPLETED
Bridging Intestinal Failure With Teduglutide - a Case Report
Lead Sponsor:
Medical University of Vienna
Conditions:
Short Bowel Syndrome
Eligibility:
MALE
Brief Summary
In this case report the investigators present a novel strategy for using teduglutide as a bridging therapy to intestinal reconstruction.
Eligibility Criteria
Inclusion
- short bowel syndrome
Exclusion
- \<18 years
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT04916665
Start Date
January 1 2019
End Date
December 31 2019
Last Update
June 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria